Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dendreon Corporation
Dendreon Announces Common Stock Offering
May 24th, 2009
Dendreon Corporation (NASDAQ: DNDN) announced the pricing of an underwritten public offering of 10,700,000 shares of its common stock. Deutsche Bank Securities will act as sole manager for the offering. Dendreon has granted Deutsche Bank Securities an option to purchase an additional 1,279,166 shares of common stock to cover over-allotments, if any. Dendreon intends to use the net proceeds of the offering to develop manufacturing facilities, a distribution network, an information technology platform and other infrastructure, to hire sales and marketing, manufacturing, quality and other personnel in preparation for the licensure by the FDA and commercialization of...
Source: Pharma Investments, Ventures & Law Weekly (2009-05-24)
|
